Elevance Health, Inc. News
Elevance Health, Inc. operates as a health benefits company. The company operates through four segments: Commercial & Specialty Business, Government Business, CarelonRx, and Other. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was founded in 1944 and is based in Indianapolis, Indiana.
see moreElevance Health, Inc. Market News
26 Jul at 17:58
Elevance Health's Stock Decline Amidst Strong Earnings and Medicaid Concerns
- Elevance Health's stock drops despite strong Q2 earnings due to Medicaid concerns.
19 Jul at 17:56
Elevance Health's Q2 2026 Earnings Beat Expectations Amid Medicaid Concerns
Elevance Health reports strong Q2 2026 earnings but faces Medicaid challenges.
12 Jul at 17:54
Elevance Health's Stock Performance Amid Recent Analyst Downgrades and Institutional Movements
Elevance Health faces analyst downgrades and institutional stake reductions.
07 Jul at 04:37
Elevance Health's Stock Performance Amid Recent Analyst Upgrades and Institutional Movements
Elevance Health's stock sees positive momentum following analyst upgrades and institutional investments.
25 May at 04:36
Elevance Health: Upgrades, Medicare Drop & CMS Hit
This week brought material developments for Elevance Health (ELV): major analyst upgrades lifted sentiment, but a steep decline in Medicare Advantage membership and a $935M CMS-related accrual materially pressured operating results. Together these factors shape a near-term recovery narrative tempered by regulatory risk.
18 May at 04:36
Elevance Q1 Beat, CMS Risk Overhang Shapes ELV Now
Elevance Health delivered a solid Q1 beat and raised 2026 guidance, but a $935M CMS-related accrual and an approaching May 30 CMS deadline keep regulatory risk front-and-center for ELV. Shareholder votes affirmed management, and cash flow and buybacks supported near-term confidence. The stock’s outlook now pivots on CMS actions and medical-cost trends.
